A detailed history of New England Capital Financial Advisors LLC transactions in Embecta Corp. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 31 shares of EMBC stock, worth $438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 30 3.33%
Holding current value
$438
Previous $405,000 4.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$10.13 - $14.6 $10 - $14
1 Added 3.33%
31 $386,000
Q2 2023

Aug 02, 2023

BUY
$21.6 - $30.69 $21 - $30
1 Added 3.45%
30 $640,000
Q4 2022

Feb 03, 2023

BUY
$25.29 - $35.48 $733 - $1,028
29 New
29 $695,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $819M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track New England Capital Financial Advisors LLC Portfolio

Follow New England Capital Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Capital Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Capital Financial Advisors LLC with notifications on news.